Periodic Reporting for period 1 - wellwatch (A hands-free remote monitoring solution for continuous and accurate medical grade assessment of heart health)
Reporting period: 2017-02-01 to 2017-04-30
• Multiuser audience surveys determining form factors, the prototype specification, preferred materials identification plus, an environmental assessment to identify the C2C certification requirements.
• A cost benefit analysis produced manufacturing methods and a selection of manufacturing partners based on cost effectiveness, manufacturing methods, ability to scale and environmental impact
• Through analysis of market reports, a report with SWOT analysis was produced validating entry geographies, ranking, with identification of the top 3 countries for market entry.
• Input from clinical expert opinion created a clinical and regulatory strategy alongside a rigorous plan for Wellwatch certification.
• Voice of customer interviews collected from KOLs established and validate the business model proposed, and develop the preferred care pathway and reimbursement models.
• A data ownership plan addressing data pathways, usage rights, liability and security for all potential end users resulted with a choice of data implementation partners.
• Following outcomes of this action, the Business Plan focused on the commercial model as well as EU-wide dissemination to produce an updated market analysis. IP strategy was expert assessed, and strategic partners identified to assist with dissemination and commercialisation.